{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:04:09Z","timestamp":1770822249363,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.cancergencyto.2008.11.007","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T13:30:23Z","timestamp":1234359023000},"page":"112-117","source":"Crossref","is-referenced-by-count":12,"title":["Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment"],"prefix":"10.1016","volume":"189","author":[{"given":"Olga","family":"Pozdnyakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Crowley-Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Zota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.","family":"Miron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2008.11.007_bib1","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours","year":"2001"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis","volume":"66","author":"Dewald","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.V71.2.453.453","article-title":"Plasma cell karyotype in multiple myeloma","volume":"71","author":"Gould","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","article-title":"Cytogenetic findings in 200 patients with multiple myeloma","volume":"82","author":"Sawyer","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1034\/j.1600-0609.2002.00724.x","article-title":"Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation","volume":"68","author":"Nilsson","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib7","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1200\/JCO.2005.05.023","article-title":"Prognostic and therapeutic significance of myeloma genetics and gene expression profiling","volume":"23","author":"Stewart","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.cancergencyto.2008.11.007_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF03165279","article-title":"New insights into role of microenvironment in multiple myeloma","volume":"76","author":"Tricot","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib9","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib10","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/sj.leu.2404304","article-title":"Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma","volume":"20","author":"Chiecchio","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/sj.leu.2404330","article-title":"The role of cytogenetics in myeloma","volume":"20","author":"Zhan","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.1996.d01-2939.x","article-title":"Multiple myeloma: almost all patients are cytogenetically abnormal","volume":"94","author":"Zandecki","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/10428190500464104","article-title":"Clinical implications of chromosomal abnormalities in multiple myeloma","volume":"47","author":"Terpos","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s002770100366","article-title":"New insights into the biology of multiple myeloma using a combination of May\u2013Gr\u00fcnwald\u2013Giemsa staining and fluorescence in situ hybridization techniques at the single cell level","volume":"80","author":"Nickenig","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-1759(99)00199-4","article-title":"Isolation and characterization of human multiple myeloma cell enriched populations","volume":"235","author":"Tai","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002770000245","article-title":"Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement","volume":"80","author":"Draube","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.leu.2403586","article-title":"Intergroupe Francophone de My\u00e9lome. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma","volume":"19","author":"Wuilleme","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1046\/j.1365-2141.2003.04172.x","article-title":"Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results","volume":"120","author":"Harrison","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib21","series-title":"The AGT cytogenetics laboratory manual","year":"1997"},{"key":"10.1016\/j.cancergencyto.2008.11.007_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2006.11.015","volume":"174","author":"Christensen","year":"2007","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808006699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808006699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:19:39Z","timestamp":1589559579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460808006699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0165460808006699"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.11.007","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}